CO4370021A1 - HYDROXAMIC ACID DERIVATIVES OF SUBSTITUTED SUCCINIC ACID - Google Patents

HYDROXAMIC ACID DERIVATIVES OF SUBSTITUTED SUCCINIC ACID

Info

Publication number
CO4370021A1
CO4370021A1 CO95016836A CO95016836A CO4370021A1 CO 4370021 A1 CO4370021 A1 CO 4370021A1 CO 95016836 A CO95016836 A CO 95016836A CO 95016836 A CO95016836 A CO 95016836A CO 4370021 A1 CO4370021 A1 CO 4370021A1
Authority
CO
Colombia
Prior art keywords
lower alkyl
atomo
carbamoil
amino
ring
Prior art date
Application number
CO95016836A
Other languages
Spanish (es)
Inventor
Michael John Broadhurst
Paul Anthony Brown
William Henry Johnson
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CO4370021A1 publication Critical patent/CO4370021A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

REIVINDICACION NUMERO COMPUESTOS DE LA FORMULA GENERAL FIGURA 1 EN DONDE R1 REPRESENTA CICLOPROPILO, CICLOBUTILO, CICLOPEN- TILO O CICLOHEXILO; R2 REPRESENTA UN ANILLO N-HETEROCICLICO MONOCICLI- CO O PUENTEADO DE 5 A 8 MIEMBROS SATURADO QUE ESTA UNIDO VIA EL ATOMO DE N Y QUE, CUANDO ES MONOCI- CLICO, CONTIENE OPCIONALMENTE NR4, O, SO o SO2 COMO UN MIEMBRO DE ANILLO Y/O ESTA OPCIONALMENTE SUSTITUIDO EN UNO O MAS ATOMOS DE C POR HIDROXILO, ALQUILO INFERIOR, ALCOXILO INFERIOR, OXO, OXO CE- TALIZADO, AMINO, MONO(ALQUILO INFERIOR)AMINO, DI(ALQUILO INFERIOR) AMINO, CARBOXILO, ALCOXICAR- BONILO INFERIOR, HIDROXIMETILO, ALCOXIMETILO INFE- RIOR, CARBAMOILO, MONO(ALQUILO INFERIOR)-CARBAMOI- LO, DI(ALQUILO INFERIOR) CARBAMOILO O HIDROXIIMI- NO; R3 REPRESENTA UN ANILLO N-HETEROCICLICO PENTAGONAL O HEXAGONAL QUE (a) ESTA UNIDO VIA EL ATOMO DE N, (b) OPCIONALMENTE CONTIENE N, O y/o S, SO o SO2 COMO UN MIEMBRO DE ANILLO ADICIONAL, (c) ESTA CONSTITUIDO POR OXO EN UNO O AMBOS ATOMOS DE C ADYACENTE EL ATOMO C ADYACENTE EL ATOMO DE N DE ENLACE Y (d) ESTA OPCIONALMENTE SUSTITUIDO EN UNO O MAS ATOMOS DE OTROS ATOMOS POR C POR ALQUILO INFERIOR O OXO Y/O EN CUALQUIER ATOMO(S) DE N ADICIONAL(ES) POR ALQUILO INFERIOR O ARILO; R4 REPRESENTA HIDROGENO, ALQUILO INFERIOR, ARILO, ARALQUILO O UN GRUPO PROTECTOR; m SIGNIFICA 1 o 2; Y n SIGNIFICA 1-4; Y SUS SALES FARMACEUTICAMENTE ACEPTABLES".CLAIMS NUMBER OF COMPOUNDS OF THE GENERAL FORMULA FIGURE 1 WHERE R1 REPRESENTS CYCLOPROPYL, CYCLOBUTYL, CYCLOPHENYL OR CYCLLOHEXYL; R2 REPRESENTS A 5 TO 8 MEMBER SINGLE-BRIDGED N-HETERO-CYCLE OR BRIDGED RING THAT IS UNITED VIA THE NY ATOM WHICH, WHEN IT IS MONOCYCLIC, OPTIONALLY CONTAINS NR4, OR, SO, OR SO2 AS A RING MEMBER AND / OR IT IS OPTIONALLY REPLACED IN ONE OR MORE ATOMS OF C BY HYDROXYL, LOWER ALKYL, LOWER ALCOXYL, OX, CE-SIZED, AMINO, MONO (LOWER ALKYL) AMINO, DI (LOWER ALKYL) AMINO, CARBOXYL, ALCL HYDROXYMETHYL, LOWER ALCOXYMETHYL, CARBAMOIL, MONKEY (LOWER ALKYL) -CARBAMOIL, DI (LOWER ALKYL) CARBAMOIL OR HYDROXYMYLON; R3 REPRESENTS A PENTAGONAL OR HEXAGONAL N-HETERO CYCLIC RING WHICH (a) IS UNITED VIA THE ATOM OF N, (b) OPTIONALLY CONTAINS N, O and / or S, SO or SO2 AS AN ADDITIONAL RING MEMBER, (c) IS ESTABLISHED BY OXO IN ONE OR BOTH ATOMS OF C ADJACENT ATOMO C ADJACENTE ATOMO DE N DE LINK AND (d) IS OPTIONALLY SUBSTITUTED IN ONE OR MORE ATOMOS OF OTHER ATOMOS BY C BY LOWER ALKYL OR OXO AND / OR IN ANY ATOMO (S ) OF ADDITIONAL N (S) FOR LOWER RENT OR ARIL; R4 REPRESENTS HYDROGEN, LOWER RENT, ARYL, ARACHYL OR A PROTECTIVE GROUP; m MEANS 1 or 2; Y n MEANS 1-4; AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS. "

CO95016836A 1994-04-25 1995-04-24 HYDROXAMIC ACID DERIVATIVES OF SUBSTITUTED SUCCINIC ACID CO4370021A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9408183A GB9408183D0 (en) 1994-04-25 1994-04-25 Hydroxamic acid derivatives

Publications (1)

Publication Number Publication Date
CO4370021A1 true CO4370021A1 (en) 1996-10-07

Family

ID=10754086

Family Applications (1)

Application Number Title Priority Date Filing Date
CO95016836A CO4370021A1 (en) 1994-04-25 1995-04-24 HYDROXAMIC ACID DERIVATIVES OF SUBSTITUTED SUCCINIC ACID

Country Status (10)

Country Link
BR (1) BR9501765A (en)
CO (1) CO4370021A1 (en)
GB (1) GB9408183D0 (en)
HR (1) HRP950251B1 (en)
PE (1) PE2496A1 (en)
PL (1) PL179129B1 (en)
SV (1) SV1995000020A (en)
UY (1) UY23953A1 (en)
YU (1) YU48933B (en)
ZA (1) ZA953123B (en)

Also Published As

Publication number Publication date
YU24795A (en) 1997-12-05
PL308327A1 (en) 1995-10-30
GB9408183D0 (en) 1994-06-15
PL179129B1 (en) 2000-07-31
YU48933B (en) 2002-12-10
SV1995000020A (en) 1995-10-04
UY23953A1 (en) 1995-10-16
BR9501765A (en) 1995-11-21
ZA953123B (en) 1996-01-09
HRP950251A2 (en) 1997-08-31
HRP950251B1 (en) 2001-06-30
PE2496A1 (en) 1996-02-12

Similar Documents

Publication Publication Date Title
ES2150513T3 (en) DERIVATIVES OF HYDROXAMIC ACID WITH TRICYCLIC SUBSTITUTION.
ES2193208T3 (en) NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
PA8431301A1 (en) METALOPROTEINASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PHARMACEUTICAL USES AND USEFUL METHODS AND INTERMEDIATES FOR THEIR PREPARATION
NO933482D0 (en) N-SULPHONYL-2-OXOINDOL DERIVATIVES WHICH HAVE AFFINITY OF VASOPRESSIN AND / OR OCYTOCIN RECEPTORS
BR0012697A (en) Th2 differentiation inhibitors
ATE159950T1 (en) N-ALKYL-2-SUBSTITUTED ATP ANALOGUES
NZ238181A (en) N-(1-substituted-piperidinyl(alkyl))carbamic acid, urea and carboxamide derivatives and homologues thereof; preparatory processes and pharmaceutical compositions
ES2067456T3 (en) NEW AMINO ACID DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM.
ES2055056T3 (en) DERIVATIVES OF PIRIMIDOPIRIMIDINA.
DE69232854T2 (en) BIZYCLIC FIBRINOGENIC ANTAGONISTS
ES2123829T3 (en) DERIVATIVES OF 3- (5-TETRAZOLIL-BENCIL) AMINO-PIPERIDINE AND TACHYQUIN ANTAGONISTS.
ES2181766T3 (en) ANALOGS OF DELDA 12,13-ISOTAXOL, ANTINEOPLASIC USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FI941457A0 (en) Cyclic compounds useful as inhibitors of platelet glycoprotein IIb / IIIa
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
DK0629635T3 (en) New 19-nor-11beta-phenoxysulfonamide or 11beta-phenoxysulfonylurea steroids, process and intermediates for their preparation, their use as pharmaceuticals and pharmaceutical compositions containing them
AR030423A1 (en) HERBICIDE COMPOSITIONS BASED ON SUBSTITUTED CARBOXAMIDS
ES2146643T3 (en) FENILCARBOXAMIDA-ISOXAZOLES AND ITS SALTS, ITS PREPARATION PROCEDURE, ITS APPLICATION AS DRUGS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
CO4370021A1 (en) HYDROXAMIC ACID DERIVATIVES OF SUBSTITUTED SUCCINIC ACID
SE9001269L (en) 2-SUBSTITUTED N, N'-DITRIMETOXBENZOYL PIPERAZINES, AND A PREPARATION METHOD FOR THESE AND THERAPEUTIC COMPOSITIONS CONTAINING THEM
ES457783A1 (en) Basic substituted xanthine derivatives
DOP2002000518A (en) AZAPOLICICLIC COMPOUNDS CONDENSED WITH ARILO
HUP0003548A2 (en) 2-acylaminopropanamines as tachykinin receptor antagonists and pharmaceutical compositions containing the same
AR248276A1 (en) Imidazolidine derivatives, process for producing the same and pesticides containing the same
ES2078723T3 (en) 3-ACILAMINO-2-PIRROLIDINONAS AS ENHANCERS OF THE LEARNING PROCESSES AND OF THE MEMORY AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ES2060545B1 (en) A PROCEDURE TO PRODUCE AN OPTICALLY ACTIVE BENZO (B) TIOFEN-5-ILO DERIVATIVE.